Septic shock and disturbances in coagulation.
D000138:Acidosis / Q000209:etiology; D058186:Acute Kidney Injury / Q000150:complications; D000614:Aminocaproates / Q000627:therapeutic use; D001241:Aspirin / Q000009:adverse effects; D001778:Blood Coagulation Disorders / Q000209:etiology; D001779:Blood Coagulation Factors / Q000378:metabolism; D002302:Cardiac Output; D003509:Cyclohexanecarboxylic Acids / Q000627:therapeutic use; D004211:Disseminated Intravascular Coagulation / Q000209:etiology / Q000628:therapy; D005340:Fibrinogen / Q000378:metabolism; D005342:Fibrinolysis; D006471:Gastrointestinal Hemorrhage / Q000150:complications; D006801:Humans; D000860:Hypoxia / Q000209:etiology; D008171:Lung Diseases / Q000209:etiology; D008744:Methylamines / Q000627:therapeutic use; D012131:Respiratory Insufficiency / Q000209:etiology; D012772:Shock, Septic / Q000150:complications / Q000628:therapy; D065227:Transfusion Reaction
D000614:Aminocaproates; D001779:Blood Coagulation Factors; D003509:Cyclohexanecarboxylic Acids; D008744:Methylamines; D005340:Fibrinogen; D001241:Aspirin